Search Results for: Fosamax

Featured Stories

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Dozens Receive Nonsterile Simulated Saline Solution

Dozens-Receive-Nonsterile-Simulated-Saline-Solution

The FDA said last week that more than 40 patients had received intravenous simulated saline that was not sterile and was not intended for human use.

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

MTA Bus Crash and Two Cars Injures 23 at Utica Ave. & Clarendon Rd

Crash Involving MTA Bus and Two Cars Injures 23

Police are investigating an accident in Brooklyn on Wednesday afternoon that injured 23 people, 3 of them critically, when a car was knocked into the path of an MTA bus.

Read More

Judge Delays Fosamax MDL “Wind-Down”

judge_delays_fosamax_lawsuit

To enable plaintiffs and Merck &  Co. Inc. time to work on a potential settlement, a New York federal judge delayed the transfer of hundreds of lawsuits that are part of a multidistrict litigation (MDL) brought over alleged jaw injuries … Continue reading

Posted in Fosamax, Pharmaceuticals |

Hundreds of Fosamax Lawsuits Being Sent to Trial

fosamax_lawsuits_go_through

A federal judge just ordered hundreds of cases involved in a multidistrict litigation (MDL) brought against Merck & Co. over alleged Fosamax jaw injuries be sent for trial in courts nationwide. Fosamax is Merck’s osteoporosis medication. Drug and device manufacturers … Continue reading

Posted in Fosamax, Pharmaceuticals |

Judge Denies Merck’s Request to Force Fosamax Plaintiffs To Verify Injuries

judge_denies_merck_fosamax_verification

This week, a New York federal judge denied a request to mandate hundreds of alleged Fosamax victims to substantiate their injuries. Fosamax is manufactured by Merck & Co. U.S. District Judge John Keenan refused the request that would not only … Continue reading

Posted in Fosamax, Pharmaceuticals |

Judge Overrules Merck’s Bid to Boot Expert Testimony from Four Doctors in Fosamax Trial

Merck and Co. was unable to stop doctors from giving expert testimony during the New Jersey-based trial, now under way, regarding osteoporosis drug Fosamax for allegedly causing atypical femur fractures. The federal judge ruled, however, that while the plaintiff’s treating … Continue reading

Posted in Fosamax, Legal News, Pharmaceuticals |

Opening Statements Heard in Second Fosamax Femur Fracture Trial

The second Fosamax femur fracture trial is underway and involve allegations that Merck’s Fosamax (alendronate) caused femur fractures in some people. The trial began in New Jersey federal court and opening statements are being heard. The lawsuit is one of … Continue reading

Posted in Fosamax, Pharmaceuticals |

Fosamax Lawsuit Begins with Opening Remarks

Opening arguments today signaled the start of the second trial charging Merck’s Fosamax with causing femur fractures. In New Jersey federal court the focus was on the case of 58-year-old Bernadette Glynn, who says that the osteoporosis drug is part … Continue reading

Posted in Fosamax |

Second Fosamax Femur Injury Trial Underway

Merck & Company, the maker of Fosamax (alendronate), is facing a second of thousands of cases brought by plaintiffs who allege they suffered Fosamax injuries. The first lawsuit recently ended in a mistrial unrelated to the injury allegations. The plaintiff … Continue reading

Posted in Fosamax, Pharmaceuticals |

Halted Fosamax Trial Re-Scheduled

We recently wrote that drug maker, Merck & Company, was scheduled to face its second round of Fosamax (alendronate) lawsuits in New Jersey over allegations that the bone drug causes femur fractures. The trial is scheduled to start next week … Continue reading

Posted in Fosamax, Pharmaceuticals |

Merck Readying for 2nd Round of New Jersey Fosamax Lawsuits

Drug maker, Merck & Company will be facing its second round of Fosamax (alendronate) lawsuits in New Jersey over allegations that the bone drug causes femur fractures. Jury selections is set to begin next week in the first of some … Continue reading

Posted in Fosamax, Pharmaceuticals |

Woman who suffered jawbone loss due to Fosamax reaches damages settlement with Merck

A woman who claims her taking Fosamax in the prevention of bone loss caused by osteoporosis resulted in her developing decay of her jaw bone has reached a confidential settlement with the makers of the drug. Merck & Co. has … Continue reading

Posted in Bisphosphonates, Fosamax, Legal News, Pharmaceuticals | Tagged , |

© 2005-2015 Parker Waichman LLP ®. All Rights Reserved.